Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in France-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in France

Published:2022-04-05 Issue:5 Volume:22 Page:411-418
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Leblanc Soline¹,Lefort Mathilde¹,Le Page Emmanuelle²³,Michel Laure²³,Leray Emmanuelle¹²^ORCID

Affiliation:

1. Univ Rennes, EHESP, CNRS, Inserm, ARENES – UMR 6051, RSMS – U 1309, F-35000 Rennes, Rennes, France

2. INSERM CIC-P 1414, CRC-SEP Rennes University Hospital, Rennes University, Rennes, France

3. Neurology department, Rennes University Hospital, Rennes University, Rennes, France

Funder

Institut des Neurosciences Cliniques de Rennes

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Neurology (clinical),General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737175.2022.2061950

Reference21 articles.

1. Diagnosis and Treatment of Multiple Sclerosis

2. Disease-modifying therapy usage in patients with multiple sclerosis in France: A 6-year population-based study

3. An analysis of first-line disease-modifying therapies in patients with relapsing-remitting multiple sclerosis using the French nationwide health claims database from 2014–2017

4. Untreated patients with multiple sclerosis: A study of French expert centers

5. French national health insurance information system and the permanent beneficiaries sample

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical implications for the association of psoriasis and multiple sclerosis: an observational study;Neurological Sciences;2024-06-01

2. Disease-modifying therapy use and health resource utilisation associated with multiple sclerosis over time: A retrospective cohort study from Alberta, Canada;Journal of the Neurological Sciences;2024-03

3. Use of multiple sclerosis disease-modifying therapies during pregnancy in France: Nationwide study between 2010 and 2021;Multiple Sclerosis Journal;2024-01-27

4. The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021;Biomedical Papers;2023-04-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3